# Adaptimmune Therapeutics PLC: Form 8-K, filed Sep 12, 2025

- Company: [Adaptimmune Therapeutics PLC](/companies/adapy.md) (CIK 1621227)
- Form: 8-K
- Filed: 2025-09-12
- Accepted by EDGAR: Sep 12, 2025, 16:27 ET
- Period: 2025-09-11
- Accession: 0001104659-25-089558
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1621227/000110465925089558/adap-20250911x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1621227/000110465925089558/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1621227/000110465925089558/adap-20250911x8k.htm

Filed Sep 12, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-089558. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.